Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lorlatinib - PF-06463922

NCT03127618 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03127618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03127618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lorlatinib - PF-06463922
Lead sponsor
Pfizer
Phase
Expanded access
Overall status
Approved for marketing
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported